CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC).
Author
Angemael Syldor
Chau T. Dang
+18Â more
Clifford Hudis
Conleth G. Murphy
Devika Gajria
Diana Lake
Elizabeth Anne Comen
Farrah Mikhail Datko
Gabriella D'Andrea
Jennifer Liu
Julie Fasano
Maria Theodoulou
Maura N. Dickler
Monica Nancy Fornier
Nancy T. Sklarin
Pamela Drullinsky
Sarat Chandarlapaty
Shanu Modi
Shari Beth Goldfarb
Sujata Patil
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref